Ulima Nitra Tbk PT
IDX:UNIQ
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
194
735
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Ulima Nitra Tbk PT
Balance Sheet
Balance Sheet Decomposition
Ulima Nitra Tbk PT
| Current Assets | 339.6B |
| Cash & Short-Term Investments | 11.8B |
| Receivables | 313.4B |
| Other Current Assets | 14.4B |
| Non-Current Assets | 469.6B |
| PP&E | 469.5B |
| Other Non-Current Assets | 37.9m |
| Current Liabilities | 288.9B |
| Accounts Payable | 33.7B |
| Accrued Liabilities | 51.9B |
| Short-Term Debt | 60.4B |
| Other Current Liabilities | 142.8B |
| Non-Current Liabilities | 87.7B |
| Long-Term Debt | 73.5B |
| Other Non-Current Liabilities | 14.2B |
Balance Sheet
Ulima Nitra Tbk PT
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
4 745
|
20 702
|
11 917
|
1 289
|
565
|
41 091
|
11 574
|
|
| Cash |
0
|
0
|
0
|
0
|
565
|
41 091
|
11 574
|
|
| Cash Equivalents |
4 745
|
20 702
|
11 917
|
1 289
|
0
|
0
|
0
|
|
| Total Receivables |
51 587
|
46 699
|
124 475
|
130 885
|
133 196
|
147 487
|
237 308
|
|
| Accounts Receivables |
51 295
|
46 549
|
118 929
|
130 376
|
132 443
|
144 622
|
236 507
|
|
| Other Receivables |
292
|
151
|
5 546
|
509
|
753
|
2 865
|
801
|
|
| Inventory |
0
|
0
|
1 653
|
3 529
|
3 869
|
5 456
|
5 430
|
|
| Other Current Assets |
4 937
|
4 435
|
3 176
|
43 802
|
12 176
|
26 902
|
6 315
|
|
| Total Current Assets |
61 269
|
71 836
|
141 222
|
179 505
|
149 807
|
220 936
|
260 627
|
|
| PP&E Net |
368 390
|
415 877
|
436 402
|
355 202
|
352 653
|
353 894
|
465 603
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
353 894
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
414 851
|
0
|
|
| Note Receivable |
5 270
|
5 270
|
0
|
4 417
|
11 071
|
6 655
|
0
|
|
| Other Long-Term Assets |
4 146
|
0
|
2 955
|
31
|
2 489
|
32
|
37
|
|
| Total Assets |
439 074
N/A
|
492 983
+12%
|
580 579
+18%
|
539 154
-7%
|
516 020
-4%
|
581 518
+13%
|
726 266
+25%
|
|
| Liabilities | ||||||||
| Accounts Payable |
25 543
|
23 644
|
34 085
|
42 660
|
38 567
|
41 417
|
41 397
|
|
| Accrued Liabilities |
5 485
|
11 139
|
5 816
|
6 193
|
11 932
|
13 985
|
18 378
|
|
| Short-Term Debt |
15 803
|
0
|
62 294
|
92 040
|
49 343
|
50 489
|
60 156
|
|
| Current Portion of Long-Term Debt |
65 163
|
86 578
|
92 559
|
66 125
|
51 498
|
49 431
|
111 420
|
|
| Other Current Liabilities |
18 239
|
10 831
|
17 446
|
2 736
|
3 233
|
6 377
|
4 332
|
|
| Total Current Liabilities |
130 233
|
132 191
|
212 200
|
209 754
|
154 573
|
161 699
|
235 684
|
|
| Long-Term Debt |
54 859
|
90 472
|
86 134
|
48 229
|
21 035
|
51 433
|
93 224
|
|
| Deferred Income Tax |
0
|
789
|
0
|
1 428
|
0
|
6 826
|
4 181
|
|
| Other Liabilities |
3 187
|
3 508
|
3 749
|
4 353
|
3 367
|
2 479
|
3 271
|
|
| Total Liabilities |
188 279
N/A
|
226 960
+21%
|
302 083
+33%
|
263 764
-13%
|
178 975
-32%
|
222 437
+24%
|
336 359
+51%
|
|
| Equity | ||||||||
| Common Stock |
5 000
|
5 000
|
5 000
|
5 000
|
6 278
|
6 278
|
6 278
|
|
| Retained Earnings |
239 105
|
254 245
|
266 679
|
263 934
|
261 079
|
283 115
|
313 940
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
69 688
|
69 688
|
69 688
|
|
| Other Equity |
6 690
|
6 777
|
6 818
|
6 457
|
0
|
0
|
0
|
|
| Total Equity |
250 795
N/A
|
266 023
+6%
|
278 496
+5%
|
275 391
-1%
|
337 045
+22%
|
359 081
+7%
|
389 906
+9%
|
|
| Total Liabilities & Equity |
439 074
N/A
|
492 983
+12%
|
580 579
+18%
|
539 154
-7%
|
516 020
-4%
|
581 518
+13%
|
726 266
+25%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
2 500
|
2 500
|
2 500
|
2 500
|
3 139
|
3 139
|
3 139
|
|
You don't have any saved screeners yet
